Although this study contributes to the growing evidence supporting a dermatologic role for GLP-1-based therapies, larger controlled trials are needed to confirm these observations, clarify underlying mechanisms, and inform their integration into routine dermatologic practice
Biochim Biophys Acta 1830:330416
Retatrutide is an emerging medication that targets three hormone receptors instead of two, which early studies suggest may produce even stronger metabolic and weight-loss effects
Theyve been synthesizing peptides in-house in Southern California for over 12 years
Frequently asked questions If youve been on a therapeutic dose for several months and havent noticed any reduction in appetite, cravings, or weight (even with consistent lifestyle efforts), it may be worth discussing with your healthcare provider
[GLP-1 meds] are a game changer, says Michael Treskow, partner at Eight Roads Ventures, adding it would be strange if a startup working in the weight loss space wasnt looking into how they could add the drugs into their offering
